Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02730715 · ClinicalTrials.gov registry record
Effect of Thymoglobulin Versus Basiliximab on Regulatory T Cell Function in Live Donor Kidney Transplant Recipients
A clinical trial, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- 30
- Enrollment target
NCT02730715: Clinical Trial study, sponsored by University of Pennsylvania.
NCT02730715 is a clinical trial that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02730715 was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study aims to study the effects that two standard of care immunosuppression induction regimens have on regulatory T cells (Treg) in live donor renal transplant recipients. Both regimens are currently used in this hospital for early immunosuppression induction but the effects on Treg numbers and function is not well understood and likely will impact long term immune function.
Primary Outcome
Each sample will be measured by flow cytometry. Data will be analyzed for each treatment arm using nonparametric statistical tests and expressed as the medium value and inter-quartile range.
Interventions
- DRUG Thymoglobulin
- DRUG Basiliximab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-11 |
| Est. Completion | 2020-04 |
Why NCT02730715 stopped before completion
NCT02730715 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Thymoglobulin is the first listed.
NCT02730715 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02730715 about?
NCT02730715 is a clinical study titled "Effect of Thymoglobulin Versus Basiliximab on Regulatory T Cell Function in Live Donor Kidney Transplant Recipients". This study aims to study the effects that two standard of care immunosuppression induction regimens have on regulatory T cells (Treg) in live donor renal transplant recipients. Both regimens are currently used in this hospital for early immunosuppression induction but the effects on Treg numbers and...
What is the current status of trial NCT02730715?
This trial is currently terminated. The enrollment target is 30 participants. The study started on 2010-11. Estimated completion is 2020-04.
What interventions are being tested in trial NCT02730715?
The interventions under investigation include: Thymoglobulin (DRUG), Basiliximab (DRUG).
Who is sponsoring clinical trial NCT02730715?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia